Orlistat and CV Risk in Metabolic Syndrome
"The ORLIstat and CArdiovascular Risk Profile in Patients With Metabolic Syndrome and Type 2 DIAbetes (ORLICARDIA) Study"
'96 Batch Blog
Welcome to the '96 Batch Medical College Trivandrum Blog Page!
Friday, October 22, 2004
About Me
- Name: Dr. Kay
- Location: Mumbai, Maharashtra, India
I'm a resident in Orthopaedics and am interested in computers, movies, music and books. I'm in a rock band and am an aspiring songwriter as well.
Previous Posts
- Polycystic Ovary Syndrome May Lead to Diabetes, Ca...
- Hypertension -- Unique Phenotypes and Antihyperten...
- Hypertension -- Unique Phenotypes and Antihyperten...
- Nobel Prize for Medicine Awarded to U.S. Scientist...
- "Humans have just 20,000 to 25,000 genes - well do...
- PCWorld.com - Study Details Mobile Phone Dangers
- Air, Not Oxygen, Should Be Used First for Neonatal...
- Cystatin C Improves Early Risk Stratification of P...
- Vioxx Withdrawal Prompts Reevaluation of COX-2 Inh...
- Vioxx Withdrawal Prompts Reevaluation of COX-2 Inh...
0 Comments:
Post a Comment
<< Home